{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:04:24Z","timestamp":1792227864662,"version":"4.4.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T00:00:00Z","timestamp":1730246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100018074","name":"Weill Institute for Neurosciences, University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018074","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG062422"],"award-info":[{"award-number":["P30AG062422"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG062422"],"award-info":[{"award-number":["P30AG062422"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG062422"],"award-info":[{"award-number":["P30AG062422"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG062422"],"award-info":[{"award-number":["P30AG062422"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARG-20-678884"],"award-info":[{"award-number":["AARG-20-678884"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-024-02816-9","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T11:48:15Z","timestamp":1730288895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Comprehensive mapping of synaptic vesicle protein 2A (SV2A) in health and neurodegenerative diseases: a comparative analysis with synaptophysin and ground truth for PET-imaging interpretation"],"prefix":"10.1007","volume":"148","author":[{"given":"Mahsa","family":"Shanaki Bavarsad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Oehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel E.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia K.","family":"Suemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata E. P.","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Seeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jagust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil D.","family":"Rabinovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea T.","family":"Grinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,30]]},"reference":[{"key":"2816_CR1","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/mds.28617","volume":"36","author":"KB Andersen","year":"2021","unstructured":"Andersen KB, Hansen AK, Damholdt MF et al (2021) Reduced synaptic density in patients with lewy body dementia: an [11 C]UCB-J PET Imaging Study. Mov Disord 36:2057\u20132065. https:\/\/doi.org\/10.1002\/mds.28617","journal-title":"Mov Disord"},{"key":"2816_CR2","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.jalz.2015.12.005","volume":"12","author":"MC de Wilde","year":"2016","unstructured":"de Wilde MC, Overk CR, Sijben JW, Masliah E (2016) Meta-analysis of synaptic pathology in Alzheimer\u2019s disease reveals selective molecular vesicular machinery vulnerability. Alzheimers Dement 12:633\u2013644. https:\/\/doi.org\/10.1016\/j.jalz.2015.12.005","journal-title":"Alzheimers Dement"},{"key":"2816_CR3","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/brain\/awab282","volume":"145","author":"N Holland","year":"2022","unstructured":"Holland N, Malpetti M, Rittman T et al (2022) Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and PET study. Brain 145:340\u2013348. https:\/\/doi.org\/10.1093\/brain\/awab282","journal-title":"Brain"},{"key":"2816_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/ana.26543","volume":"93","author":"M Malpetti","year":"2023","unstructured":"Malpetti M, Jones PS, Cope TE et al (2023) Synaptic loss in frontotemporal dementia revealed by [11 C]UCB-J positron emission tomography. Ann Neurol 93:142\u2013154. https:\/\/doi.org\/10.1002\/ana.26543","journal-title":"Ann Neurol"},{"key":"2816_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP et al (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572\u2013580. https:\/\/doi.org\/10.1002\/ana.410300410","journal-title":"Ann Neurol"},{"key":"2816_CR6","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/mds.28064","volume":"35","author":"H Wilson","year":"2020","unstructured":"Wilson H, Pagano G, de Natale ER et al (2020) Mitochondrial complex 1, Sigma 1, and synaptic vesicle 2A in early drug-naive Parkinson\u2019s disease. Mov Disord 35:1416\u20131427. https:\/\/doi.org\/10.1002\/mds.28064","journal-title":"Mov Disord"},{"key":"2816_CR7","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.cell.2006.10.030","volume":"127","author":"S Takamori","year":"2006","unstructured":"Takamori S, Holt M, Stenius K et al (2006) Molecular anatomy of a trafficking organelle. Cell 127:831\u2013846. https:\/\/doi.org\/10.1016\/j.cell.2006.10.030","journal-title":"Cell"},{"key":"2816_CR8","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1002\/jnr.22392","volume":"88","author":"R Clare","year":"2010","unstructured":"Clare R, King VG, Wirenfeldt M, Vinters HV (2010) Synapse loss in dementias. J Neurosci Res 88:2083\u20132090. https:\/\/doi.org\/10.1002\/jnr.22392","journal-title":"J Neurosci Res"},{"key":"2816_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1177\/38.6.2110586","volume":"38","author":"E Masliah","year":"1990","unstructured":"Masliah E, Terry RD, Alford M, DeTeresa R (1990) Quantitative immunohistochemistry of synaptophysin in human neocortex: an alternative method to estimate density of presynaptic terminals in paraffin sections. J Histochem Cytochem 38:837\u2013844. https:\/\/doi.org\/10.1177\/38.6.2110586","journal-title":"J Histochem Cytochem"},{"key":"2816_CR10","doi-asserted-by":"publisher","first-page":"5223","DOI":"10.1523\/JNEUROSCI.14-09-05223.1994","volume":"14","author":"SM Bajjalieh","year":"1994","unstructured":"Bajjalieh SM, Frantz GD, Weimann JM et al (1994) Differential expression of synaptic vesicle protein 2 (SV2) isoforms. J Neurosci 14:5223\u20135235. https:\/\/doi.org\/10.1523\/JNEUROSCI.14-09-05223.1994","journal-title":"J Neurosci"},{"key":"2816_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/syn.22157","volume":"74","author":"K Varn\u00e4s","year":"2020","unstructured":"Varn\u00e4s K, Stepanov V, Halldin C (2020) Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non-human primate and human brain. Synapse 74:e22157. https:\/\/doi.org\/10.1002\/syn.22157","journal-title":"Synapse"},{"key":"2816_CR12","doi-asserted-by":"publisher","first-page":"348ra96","DOI":"10.1126\/scitranslmed.aaf6667","volume":"8","author":"SJ Finnema","year":"2016","unstructured":"Finnema SJ, Nabulsi NB, Eid T et al (2016) Imaging synaptic density in the living human brain. Sci Transl Med 8:348ra96. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6667","journal-title":"Sci Transl Med"},{"key":"2816_CR13","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1093\/brain\/awu190","volume":"137","author":"JL Robinson","year":"2014","unstructured":"Robinson JL, Molina-Porcel L, Corrada MM et al (2014) Perforant path synaptic loss correlates with cognitive impairment and Alzheimer\u2019s disease in the oldest-old. Brain 137:2578\u20132587. https:\/\/doi.org\/10.1093\/brain\/awu190","journal-title":"Brain"},{"key":"2816_CR14","doi-asserted-by":"publisher","first-page":"1380561","DOI":"10.3389\/fnagi.2024.1380561","volume":"16","author":"MS Bavarsad","year":"2024","unstructured":"Bavarsad MS, Grinberg LT (2024) SV2A PET imaging in human neurodegenerative diseases. Front Aging Neurosci 16:1380561. https:\/\/doi.org\/10.3389\/fnagi.2024.1380561","journal-title":"Front Aging Neurosci"},{"key":"2816_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002267","volume":"14","author":"CK Suemoto","year":"2017","unstructured":"Suemoto CK, Ferretti-Rebustini REL, Rodriguez RD et al (2017) Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional study. PLoS Med 14:e1002267. https:\/\/doi.org\/10.1371\/journal.pmed.1002267","journal-title":"PLoS Med"},{"key":"2816_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-011-0845-8","volume":"122","author":"IRA Mackenzie","year":"2011","unstructured":"Mackenzie IRA, Neumann M, Baborie A et al (2011) A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 122:111\u2013113. https:\/\/doi.org\/10.1007\/s00401-011-0845-8","journal-title":"Acta Neuropathol"},{"key":"2816_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","volume":"123","author":"TJ Montine","year":"2012","unstructured":"Montine TJ, Phelps CH, Beach TG et al (2012) National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach. Acta Neuropathol 123:1\u201311. https:\/\/doi.org\/10.1007\/s00401-011-0910-3","journal-title":"Acta Neuropathol"},{"key":"2816_CR18","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/brain\/awab099","volume":"144","author":"S Spina","year":"2021","unstructured":"Spina S, La Joie R, Petersen C et al (2021) Comorbid neuropathological diagnoses in early versus late-onset Alzheimer\u2019s disease. Brain 144:2186\u20132198. https:\/\/doi.org\/10.1093\/brain\/awab099","journal-title":"Brain"},{"key":"2816_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s00401-022-02479-4","volume":"144","author":"SF Roemer","year":"2022","unstructured":"Roemer SF, Grinberg LT, Crary JF et al (2022) Rainwater Charitable Foundation criteria for the neuropathologic diagnosis of progressive supranuclear palsy. Acta Neuropathol 144:603\u2013614. https:\/\/doi.org\/10.1007\/s00401-022-02479-4","journal-title":"Acta Neuropathol"},{"key":"2816_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13195-020-00588-4","volume":"12","author":"M Colom-Cadena","year":"2020","unstructured":"Colom-Cadena M, Spires-Jones T, Zetterberg H et al (2020) The clinical promise of biomarkers of synapse damage or loss in Alzheimer\u2019s disease. Alzheimers Res Ther 12:21. https:\/\/doi.org\/10.1186\/s13195-020-00588-4","journal-title":"Alzheimers Res Ther"},{"key":"2816_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/neur.1995.0021","volume":"4","author":"A Brun","year":"1995","unstructured":"Brun A, Liu X, Erikson C (1995) Synapse loss and gliosis in the molecular layer of the cerebral cortex in Alzheimer\u2019s disease and in frontal lobe degeneration. Neurodegeneration 4:171\u2013177. https:\/\/doi.org\/10.1006\/neur.1995.0021","journal-title":"Neurodegeneration"},{"key":"2816_CR22","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1159\/000106867","volume":"7","author":"X Liu","year":"1996","unstructured":"Liu X, Erikson C, Brun A (1996) Cortical synaptic changes and gliosis in normal aging, Alzheimer\u2019s disease and frontal lobe degeneration. Dement Geriatr Cogn Disord 7:128\u2013134. https:\/\/doi.org\/10.1159\/000106867","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"Suppl 1","key":"2816_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1159\/000051214","volume":"10","author":"I Ferrer","year":"1999","unstructured":"Ferrer I (1999) Neurons and their dendrites in frontotemporal dementia. Dement Geriatr Cogn Disord 10(Suppl 1):55\u201360. https:\/\/doi.org\/10.1159\/000051214","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2816_CR24","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1001\/archneur.58.8.1233","volume":"58","author":"AM Lipton","year":"2001","unstructured":"Lipton AM, Cullum CM, Satumtira S et al (2001) Contribution of asymmetric synapse loss to lateralizing clinical deficits in frontotemporal dementias. Arch Neurol 58:1233\u20131239. https:\/\/doi.org\/10.1001\/archneur.58.8.1233","journal-title":"Arch Neurol"},{"key":"2816_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0197-4580(90)90059-9","volume":"11","author":"SW Scheff","year":"1990","unstructured":"Scheff SW, DeKosky ST, Price DA (1990) Quantitative assessment of cortical synaptic density in Alzheimer\u2019s disease. Neurobiol Aging 11:29\u201337. https:\/\/doi.org\/10.1016\/0197-4580(90)90059-9","journal-title":"Neurobiol Aging"},{"key":"2816_CR26","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","volume":"16","author":"T G\u00f3mez-Isla","year":"1996","unstructured":"G\u00f3mez-Isla T, Price JL, McKeel DW et al (1996) Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease. J Neurosci 16:4491\u20134500. https:\/\/doi.org\/10.1523\/JNEUROSCI.16-14-04491.1996","journal-title":"J Neurosci"},{"key":"2816_CR27","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.neurobiolaging.2003.08.002","volume":"24","author":"SW Scheff","year":"2003","unstructured":"Scheff SW, Price DA (2003) Synaptic pathology in Alzheimer\u2019s disease: a review of ultrastructural studies. Neurobiol Aging 24:1029\u20131046. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2003.08.002","journal-title":"Neurobiol Aging"},{"key":"2816_CR28","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1212\/01.wnl.0000260698.46517.8f","volume":"68","author":"SW Scheff","year":"2007","unstructured":"Scheff SW, Price DA, Schmitt FA et al (2007) Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68:1501\u20131508. https:\/\/doi.org\/10.1212\/01.wnl.0000260698.46517.8f","journal-title":"Neurology"},{"key":"2816_CR29","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41582-024-00940-4","volume":"20","author":"AD Korczyn","year":"2024","unstructured":"Korczyn AD, Grinberg LT (2024) Is Alzheimer disease a disease? Nat Rev Neurol 20:245\u2013251. https:\/\/doi.org\/10.1038\/s41582-024-00940-4","journal-title":"Nat Rev Neurol"},{"key":"2816_CR30","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neurobiolaging.2023.05.003","volume":"129","author":"JD Mikkelsen","year":"2023","unstructured":"Mikkelsen JD, Kaad S, Aripaka SS, Finsen B (2023) Synaptic vesicle glycoprotein 2A (SV2A) levels in the cerebral cortex in patients with Alzheimer\u2019s disease: a radioligand binding study in postmortem brains. Neurobiol Aging 129:50\u201357. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2023.05.003","journal-title":"Neurobiol Aging"},{"key":"2816_CR31","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3389\/fncel.2019.00538","volume":"13","author":"A Metaxas","year":"2019","unstructured":"Metaxas A, Thygesen C, Briting SRR et al (2019) Increased inflammation and unchanged density of synaptic vesicle glycoprotein 2A (SV2A) in the postmortem frontal cortex of alzheimer\u2019s disease patients. Front Cell Neurosci 13:538. https:\/\/doi.org\/10.3389\/fncel.2019.00538","journal-title":"Front Cell Neurosci"},{"key":"2816_CR32","doi-asserted-by":"publisher","first-page":"fcae055","DOI":"10.1093\/braincomms\/fcae055","volume":"6","author":"V Planche","year":"2024","unstructured":"Planche V, Mansencal B, Manjon JV et al (2024) Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan. Brain Commun 6:fcae055. https:\/\/doi.org\/10.1093\/braincomms\/fcae055","journal-title":"Brain Commun"},{"key":"2816_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/jnen\/60.5.403","volume":"60","author":"EH Bigio","year":"2001","unstructured":"Bigio EH, Vono MB, Satumtira S et al (2001) Cortical synapse loss in progressive supranuclear palsy. J Neuropathol Exp Neurol 60:403\u2013410. https:\/\/doi.org\/10.1093\/jnen\/60.5.403","journal-title":"J Neuropathol Exp Neurol"},{"key":"2816_CR34","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/mds.28188","volume":"35","author":"N Holland","year":"2020","unstructured":"Holland N, Jones PS, Savulich G et al (2020) Synaptic Loss in Primary Tauopathies Revealed by [11 C]UCB-J Positron Emission Tomography. Mov Disord 35:1834\u20131842. https:\/\/doi.org\/10.1002\/mds.28188","journal-title":"Mov Disord"},{"key":"2816_CR35","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1523\/JNEUROSCI.3805-10.2011","volume":"31","author":"SA Mutch","year":"2011","unstructured":"Mutch SA, Kensel-Hammes P, Gadd JC et al (2011) Protein quantification at the single vesicle level reveals that a subset of synaptic vesicle proteins are trafficked with high precision. J Neurosci 31:1461\u20131470. https:\/\/doi.org\/10.1523\/JNEUROSCI.3805-10.2011","journal-title":"J Neurosci"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-024-02816-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-024-02816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T11:49:10Z","timestamp":1730288950000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-024-02816-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2816"],"URL":"https:\/\/doi.org\/10.1007\/s00401-024-02816-9","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,30]]},"assertion":[{"value":"15 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LTG, MS, GDR, AR and WJ received research grants from the Alliance for Therapies in Neuroscience, a partnership between the Weill Neurohub and Roche-Genentech Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"58"}}